A bacterial suspension in glycerinated medium for active immunotherapy.
Active principle: deactivated bacteria based on individual formulation. Excipients: glycerol, sodium chloride, flavour and water for injection.
The bacterial vaccines concentration is adjusted in bacteria per milliliter, quantified with turbidimetry prior to deactivation on the basis of pure bacterial mass derived from lyophilized strains managed by Inmunotek.
Recurrent upper airways infections.
Two vials at a single concentration of 1,000 million bacteria/mL (300 FTU/mL). Each puff delivers 0.1 mL. Volume per vial 9 mL.